Agf Investments Inc. Repligen Corp Transaction History

Agf Investments Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 10, 2021	SELL	$165.87 - $220.95 $154,259 - $205,483	-930 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$180.37 - $226.26 $19,479 - $24,436	-108 Reduced 10.4%	930 $181,000
Q4 2020 Feb 08, 2021	SELL	$148.08 - $206.57 $213,975 - $298,493	-1,445 Reduced 58.2%	1,038 $199,000
Q3 2020 Nov 12, 2020	BUY	$122.51 - $158.27 $22,664 - $29,279	185 Added 8.05%	2,483 $366,000
Q2 2020 Aug 11, 2020	BUY	$94.33 - $140.48 $216,770 - $322,823	2,298 New	2,298 $284,000

479

54.9M

297K

343K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.15B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.